EBV-positive diffuse large B-cell lymphoma in a human T-lymphotropic virus type 1 carrier

Infectious Agents and Cancer

Volumn 4, Issue 1, 2009, Pages

  Beltran, Brady ^a   Salas, Renzo ^a   Quĩones, Pilar ^b   Morales, Domingo ^b   Hurtado, Fernando ^a   Cotrina, Esther ^c   Riva, Luis ^a   Castillo, Jorge ^d  

^a HOSPITAL NACIONAL EDGARDO REBAGLIATI MARTINS   (Peru)

^b Edgardo Rebaglati Martins ^*  (Peru)

^c Nursing Department   (Peru)

^d BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERFERON REGULATORY FACTOR 4; PREDNISONE; VINCRISTINE; VIRUS RNA;

AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CAUSE OF DEATH; CLINICAL FEATURE; DRUG DOSE REDUCTION; DRUG RESPONSE; EPSTEIN BARR VIRUS; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN TISSUE; LARGE CELL LYMPHOMA; MALE; MULTIPLE CYCLE TREATMENT; PNEUMOCYSTIS PNEUMONIA; TREATMENT OUTCOME; VIRUS CARCINOGENESIS; VIRUS CARRIER;

EID: 68149175122     PISSN: None     EISSN: 17509378     Source Type: Journal    
DOI: 10.1186/1750-9378-4-10     Document Type: Article

References (32)

1. Epstein-Barr virus and Burkitt lymphoma. G Brady GJ MacArthur PJ Farrell, J Clin Pathol 2007 60 1397 1402 18042696
2. Cytomorphology of primary CNS lymphoma: review of 23 cases and evidence for the role of EBV. GH Yu KT Montone D Frias-Hidvegi RS Cajulis BA Brody RM Levy, Diagn Cytopathol 1996 14 114 120
3. Natural killer cell malignancies: clinicopathologic and molecular features. LL Siu JK Chan YL Kwong, Histol Histopathol 2002 17 539 554 11962758
4. HIV-associated plasmablastic lymphoma: lessons learned from 112 published cases. J Castillo L Pantanowitz BJ Dezube, Am J Hematol 2008 83 804 809 10.1002/ajh.21250 18756521
5. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. G Pallesen SJ Hamilton-Dutoit M Rowe LS Young, Lancet 1991 337 320 322 10.1016/0140-6736(91)90943-J 1671232
6. The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. S Park J Lee YH Ko A Han HJ Jun SC Lee IG Hwang YH Park JS Ahn CW Jung, Blood 2007 110 972 978 10.1182/blood-2007-01-067769 17400912 (Pubitemid 47267436)
7. S Swerdlow E Campo N Harris E Jaffe, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Lyon, France: International Agency for Research on Cancer 4 2008
8. Distribution and Pathology Characteristics of Non Hodgkin Lymphoma in Peru: A Study of 1014 Cases Using WHO Classification of Lymphoid Neoplasm. B Beltran D Morales P Quinones A Salas L Riva A Carrasco, ASH Annual Meeting Abstracts 2007 110 4419
9. Human T-cell leukemia virus type I associated lymphadenitis. K Ohshima M Kikuchi Y Masuda Y Sumiyoshi F Eguchi H Mohtai M Takeshita N Kimura, Cancer 1992 69 239 248
10. High endemicity of human T-cell lymphotropic virus type 1 among pregnant women in peru. JO Alarcon HB Friedman SM Montano JR Zunt KK Holmes GV Quinnan Jr, J Acquir Immune Defic Syndr 2006 42 604 609 16773029 10.1097/01.qai. 0000221680.52563.d5 (Pubitemid 44162431)
11. Epstein-Barr virus and cancer. MP Thompson R Kurzrock, Clin Cancer Res 2004 10 803 821 10.1158/1078-0432.CCR-0670-3 14871955 (Pubitemid 38198878)
12. Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. T Oyama K Yamamoto N Asano A Oshiro R Suzuki Y Kagami Y Morishima K Takeuchi T Izumo S Mori, Clin Cancer Res 2007 13 5124 5132 10.1158/1078-0432.CCR-06-2823 17785567 (Pubitemid 47502080)
13. Changes in the dominant Epstein-Barr virus type during human immunodeficiency virus infection. M Buisson P Morand O Genoulaz MJ Bourgeat M Micoud JM Seigneurin, J Gen Virol 1994 75 Pt 2 431 437 10.1099/0022-1317-75-2- 431 8113767
14. The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disorders. HJ Delecluse E Kremmer JP Rouault C Cour G Bornkamm F Berger, Am J Pathol 1995 146 1113 1120 7747805
15. T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly A11-positive populations by selective mutation of anchor residues. PO de Campos-Lima V Levitsky J Brooks SP Lee LF Hu AB Rickinson MG Masucci, J Exp Med 1994 179 1297 1305 7511684 10.1084/jem.179.4.1297
16. Low frequency of HLA-A*0201 allele in patients with Epstein-Barr virus-positive nasal lymphomas with polymorphic reticulosis morphology. H Kanno S Kojya T Li M Ohsawa S Nakatsuka M Miyaguchi Y Harabuchi K Aozasa, Int J Cancer 2000 87 195 199
17. Human T cell leukemia virus envelope binding and virus entry are mediated by distinct domains of the glucose transporter GLUT1. N Manel JL Battini M Sitbon, J Biol Chem 2005 280 29025 29029 10.1074/jbc.M504549200 15955807 (Pubitemid 41161351)
18. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. M Yoshida, Annu Rev Immunol 2001 19 475 496 10.1146/annurev.immunol.19. 1.475 11244044 (Pubitemid 32368043)
19. High occurrence of primary malignant neoplasms in patients with adult T-cell leukemia/lymphoma, their siblings, and their mothers. M Kozuru N Uike K Muta T Goto Y Suehiro M Nagano, Cancer 1996 78 1119 1124
20. Clinical Outcomes in Adult T Leukemia/Lymphoma: Report of 55 Cases from Peru. BE Beltran-Garate AA Carrasco-Yalan OM Lopez-Odria L Riva-Gonzales H Rios G Chumpitaz-Anchiraico S Falcon-Lisarazo J Navarro-M FH de Mendoza J Castillo-Aguirre, ASH Annual Meeting Abstracts 2005 106 4797
21. Clinical characteristics of lymphomatous form of Adult T cell lymphoma-leukemia in Peru. P Pimentel B Beltran D Flores G Ferrel S Falcon L Vera A Figueroa K Portugal V Bermudez, ASCO Meeting Abstracts 2005 23 6728
22. Shortage of circulating naive CD8(+) T cells provides new insights on immunodeficiency in aging. FF Fagnoni R Vescovini G Passeri G Bologna M Pedrazzoni G Lavagetto A Casti C Franceschi M Passeri P Sansoni, Blood 2000 95 2860 2868 10779432
23. Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people. S Koch A Larbi E Derhovanessian D Ozcelik E Naumova G Pawelec, Immun Ageing 2008 5 6 18657274 10.1186/1742-4933-5-6
24. The influence of age on T cell generation and TCR diversity. K Naylor G Li AN Vallejo WW Lee K Koetz E Bryl J Witkowski J Fulbright CM Weyand JJ Goronzy, J Immunol 2005 174 7446 7452 15905594
25. Effector T-cell induction and T-cell memory versus peripheral deletion of T cells. RM Zinkernagel D Moskophidis T Kundig S Oehen H Pircher H Hengartner, Immunol Rev 1993 133 199 223 10.1111/j.1600-065X.1993.tb01517.x 8225368
26. Resistance to apoptosis in human CD8+ T cells that reach replicative senescence after multiple rounds of antigen-specific proliferation. C Spaulding W Guo RB Effros, Exp Gerontol 1999 34 633 644 10.1016/S0531-5565(99)00033-9 10530789 (Pubitemid 29420328)
27. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. C Franceschi M Capri D Monti S Giunta F Olivieri F Sevini MP Panourgia L Invidia L Celani M Scurti, Mech Ageing Dev 2007 128 92 105 10.1016/j.mad.2006.11.016 17116321 (Pubitemid 46073065)
28. Epstein-Barr virus-related Hodgkin's disease showing B cell lineage in an immunosuppressive patient seropositive for HTLV-I. T Murata S Nakamura H Kato Y Yatabe T Shiraishi M Kuroda R Yatani T Suchi, Pathol Int 1997 47 801 805 10.1111/j.1440-1827.1997.tb04461.x 9413042
29. Epstein-Barr virus-associated Hodgkin's disease in HTLV-I seropositive patients: a report of two cases. Y Sadahira H Nishihara M Shimizu M Hirokawa H Wada O Yamada Y Yawata T Manabe, Pathol Int 1998 48 67 73 10.1111/j.1440-1827. 1998.tb03831.x 9589468
30. Epstein-Barr virus (EBV) genome carrying monoclonal B-cell lymphoma in a patient with adult T-cell leukemia-lymphoma. K Tobinai T Ohtsu M Hayashi T Kinoshita Y Matsuno K Mukai M Shimoyama, Leuk Res 1991 15 837 846 10.1016/0145-2126(91)90468-9 1656151
31. Human T cell leukemia/lymphoma virus type I (HTLV-I) and Pneumocystis carinii associated with T cell proliferation and haemophagocytic syndrome. M Roudier I Lamaury M Strobel, Leukemia 1997 11 453 454 10.1038/sj.leu.2400580 9067590
32. HTLV-1-associated adult T cell leukemia lymphoma presenting as granulomatous pneumocystis jiroveci pneumonia (PJP) and hypercalcemia. S Shahnaz D Reich D Arevalo-Valencia S Kucinska J Tulczynska J Fleischman, J Gen Intern Med 2007 22 420 423 17356979 10.1007/s11606-006-0047-6 (Pubitemid 46941225)